Certificate is a mandatory requirement for immunization to be used in Brazil. Sinovac, AstraZeneca, Pfizer and Janssen have already obtained the approval.
The National Health Surveillance Agency (Anvisa) denied, on Tuesday (30), the certification of good manufacturing practices to Bharat Biotech, an Indian biotechnology company that developed Covaxin, a vaccine candidate for Covid-19. The inspection at the Indian factory was carried out by a team of Anvisa inspectors in early March.
Among the problems pointed out are health, quality control and safety issues in the manufacture of the vaccine